Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Sonova publishes Annual Report 2024/25
Sonova publishes Annual Report 2024/25
Sonova publishes Annual Report 2024/25
Acadia Healthcare Reports First Quarter 2025 Results
Acadia Healthcare Reports First Quarter 2025 Results


Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2025.



First Quarter 2025 Highlights




  • Revenue

Financial year 2024/25: Sonova achieves market share gains across all businesses and announces upcoming CEO transition
Financial year 2024/25: Sonova achieves market share gains across all businesses and announces upcoming CEO transition
Financial year 2024/25: Sonova achieves market share gains across all businesses and announces upcoming CEO transition
Acadia Healthcare to Participate in BofA Securities Health Care Conference
Acadia Healthcare to Participate in BofA Securities Health Care Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference, May 13-15, 2025, in Las Vegas, Nevada.



In

Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 13, 2025
Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 13, 2025


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the BofA

Owens & Minor Reports First Quarter 2025 Financial Results
Owens & Minor Reports First Quarter 2025 Financial Results


Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2025.



“Across the business we continued to see strong execution and progress towards our

QuidelOrtho Reports First Quarter 2025 Financial Results: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports First Quarter 2025 Financial Results


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and

STAAR Surgical Reports First Quarter 2025 Results
STAAR Surgical Reports First Quarter 2025 Results


STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the first

Inogen Announces First Quarter 2025 Financial Results
Inogen Announces First Quarter 2025 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2025 and updated full-year 2025 guidance.



Financial Summary

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced 12-month, top-line data from its OSPREY randomized controlled trial (RCT), evaluating outcomes with the

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the

Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference:
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference


Edwards Lifesciences (NYSE: EW) today announced it will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025.



Bernard Zovighian, chief executive officer, and

Premier, Inc. Reports Fiscal-Year 2025 Third-Quarter Financial Results
Premier, Inc. Reports Fiscal-Year 2025 Third-Quarter Financial Results


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 third quarter ended March 31, 2025.



Fiscal-year

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
EQS-News: MEDICLIN increases group operating result in the first quarter of 2025
EQS-News: MEDICLIN increases group operating result in the first quarter of 2025
EQS-News: MEDICLIN increases group operating result in the first quarter of 2025
Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program
Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2025.



First Quarter 2025 Financial Highlights:




  • Revenue grew 12% year-over-year to

Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research
Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research


Agilent Technologies Inc. (NYSE: A) today announced release of the new Seahorse XF Flex Analyzer, a high-performance, 24-well system designed to expand real-time metabolic analysis into optimized

Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call
Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call


Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2025 on Thursday, May 8, 2025, before trading begins on the New York Stock Exchange.



The Company will

EQS-News: FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany
EQS-News: FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany
EQS-News: FamiCord AG continues growth course in 2024 after strong year-end business and stabilizes business development in home market Germany
EQS-News: M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings per share (+57%)
EQS-News: M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings per share (+57%)
EQS-News: M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings per share (+57%)
STAAR Surgical Announces Changes to Board of Directors
STAAR Surgical Announces Changes to Board of Directors


STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of

Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. Declares Quarterly Cash Dividend


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025


Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative

EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm
EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm
EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm